Farther Finance Advisors’s NewAmsterdam Pharma NAMS Stock Holding History

Farther Finance Advisors’s Portfolio NAMS Stock Details NAMS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$24.7K	Buy	1,017 +11	+1%	+$304	﹤0.01%	3979
2026 Q2	$34.1K	Sell	1,006 -12	-1%	-$395	﹤0.01%	3558
2026 Q1	$33.4K	Buy	1,018 +294	+41%	+$9.58K	﹤0.01%	3285
2025 Q4	$25.4K	Buy	724 +708	+4,425%	+$25.8K	﹤0.01%	3280
2025 Q3	$455	Buy	+16	New	+$384	﹤0.01%	4566

Other funds holding NAMS

TSMHT

Thurston Springer Miller Herd & Titak Indianapolis, Indiana $61.1M AUM 22.51% 1-Year Est. Return

TWD

True Wealth Design Akron, Ohio $426M AUM 16.34% 1-Year Est. Return

Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Farther Finance Advisors's NAMS Position: Q3 2026 in Review

Farther Finance Advisors increased its NewAmsterdam Pharma (NAMS) stake by 1.1% in Q3 2026, buying an estimated $304 and bringing the position to 1,017 shares worth $24.7K. The position accounts for ﹤0.01% of the portfolio, ranked #3979.

Farther Finance Advisors first reported a position in NAMS in Q3 2025 and has held it in 5 quarters since. The position peaked at $34.1K in Q2 2026. 4 funds tracked by Wall St. Rank hold NAMS as of Q3 2026.

Farther Finance Advisors held 1,017 shares of NewAmsterdam Pharma worth $24.7K as of Q3 2026.
Farther Finance Advisors bought 11 NewAmsterdam Pharma shares in Q3 2026, an estimated $304.
NewAmsterdam Pharma made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #3979 holding.
Farther Finance Advisors first reported a position in NewAmsterdam Pharma in Q3 2025 and has held it in 5 quarters since.
Farther Finance Advisors's NewAmsterdam Pharma position peaked at $34.1K in Q2 2026.
4 funds tracked by Wall St. Rank held NewAmsterdam Pharma as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.